These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients. Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192 [TBL] [Abstract][Full Text] [Related]
3. [The efficacy of recombinant vaccines against hepatitis B and the results of their use in a schedule for pediatric prophylactic inoculations]. Gorbunov MA; Pavlova LI; Titov IA; Bektimirov TA; Selezneva VP; Shitikova OIu; Mamontova TV; Indikova IN Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):55-8. PubMed ID: 9460867 [TBL] [Abstract][Full Text] [Related]
4. [Results of controlled tests of an experimental recombinant live vaccine against hepatitis B]. Ikoev VN; Gorbunov MA; Bektimirov TA; Noskova AV; Perekrest VV Vopr Virusol; 1997; 42(3):135-7. PubMed ID: 9297346 [TBL] [Abstract][Full Text] [Related]
5. Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B. Clark JR; Bartley K; Jepson CD; Craik V; March JB FEMS Immunol Med Microbiol; 2011 Mar; 61(2):197-204. PubMed ID: 21204995 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic recombinant hepatitis B vaccine in patients undergoing orthotopic liver transplantation. Berner J; Kadian M; Post J; Miller C; Schwartz M; Conn M; Borcich A Transplant Proc; 1993 Apr; 25(2):1751-2. PubMed ID: 8470152 [No Abstract] [Full Text] [Related]
7. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185 [TBL] [Abstract][Full Text] [Related]
8. [Immediate immunological effect of China-made recombinant hepatitis B vaccine expressed by transgenic Chinese hamster ovary cell line]. Liu H; Ma J; Meng Z; Zhang Y; Han C; Zhang Y; Zhao H; Liu Y; Xing Z; Chen J; Jia Z; Xia G; Cao H; Liu C; Li Z Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):43-6. PubMed ID: 11953126 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in China. Shen L; Wang F; Wang F; Cui F; Zhang S; Zheng H; Zhang Y; Liang X; Bi S Vaccine; 2012 Oct; 30(47):6623-7. PubMed ID: 22959987 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease. Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560 [TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years. Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811 [TBL] [Abstract][Full Text] [Related]
14. [Hepatitis B immunization in hemodialysis patients]. Skladaný L; Svác J; Javorský P; Kmet' M Vnitr Lek; 1998 Sep; 44(9):535-7. PubMed ID: 10358464 [TBL] [Abstract][Full Text] [Related]
15. Vaccination of newborns of HBsAg-positive carrier mothers with a recombinant DNA hepatitis B vaccine. Cadranel S; Zeghlache S; Fernandez S; Safary A; André F Postgrad Med J; 1987; 63 Suppl 2(736):159-60. PubMed ID: 3317355 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study. Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584 [TBL] [Abstract][Full Text] [Related]
17. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Watkins SL; Alexander SR; Brewer ED; Hesley TM; West DJ; Chan IS; Mendelman P; Bailey SM; Burns JL; Hogg RJ; Am J Kidney Dis; 2002 Aug; 40(2):365-72. PubMed ID: 12148110 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis. Onuigbo MA; Nesbit A; Weisenbeck J; Hurlburt J Ren Fail; 2010 May; 32(4):531-2. PubMed ID: 20446799 [TBL] [Abstract][Full Text] [Related]
19. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates. Gunn TR; Bosley A; Woodfield DG N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527 [TBL] [Abstract][Full Text] [Related]
20. [Long term results of vaccination against viral hepatitis B using recombinant vaccine Engerix B]. Juszczyk J; Barałkiewicz G Przegl Epidemiol; 1992; 46(4):271-9. PubMed ID: 1305775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]